Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 184

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas

Open access
Shankar, Ganesh M., Abedalthagafi, Malak, Vaubel, Rachael A., Merrill, Parker H., Nayyar, Naema, Gill, Corey M., Brewster, Ryan, Bi, Wenya Linda, Agarwalla, Pankaj K., Thorner, Aaron R., Reardon, David A., Al-Mefty, Ossama, Wen, Patrick Y., Alexander, Brian M., van Hummelen, Paul, Batchelor, Tracy T., Ligon, Keith L., Ligon, Azra H., Meyerson, Matthew, Dunn, Ian F., Beroukhim, Rameen, Louis, David N., Perry, Arie, Carter, Scott L., Giannini, Caterina, Curry, William T., Cahill, Daniel P., Barker, Frederick G., Brastianos, Priscilla K., Santagata, Sandro · 2016 · Neuro-Oncology

Abstract

Background: Patients with meningiomas have widely divergent clinical courses. Some entirely recover following surgery alone, while others have relentless tumor recurrences. This clinical conundrum is exemplified by rhabdoid meningiomas, which are designated in the World Health Organization Classification of Tumours as high grade, despite only a subset following an aggressive clinical course. Patient management decisions are further exacerbated by high rates of interobserver variability, biased against missing possibly aggressive tumors. Objective molecular determinants are needed to guide classification and clinical decision making. Methods: To define genomic aberrations of rhabdoid meningiomas, we performed sequencing of cancer-related genes in 27 meningiomas from 18 patients with rhabdoid features and evaluated breast cancer [BRCA]1-associated protein 1 (BAP1) expression by immunohistochemistry in 336 meningiomas. We assessed outcomes, germline status, and family history in patients with BAP1-negative rhabdoid meningiomas. Results: The tumor suppressor gene BAP1, a ubiquitin carboxy-terminal hydrolase, is inactivated in a subset of high-grade rhabdoid meningiomas. Patients with BAP1-negative rhabdoid meningiomas had reduced time to recurrence compared with patients with BAP1-retained rhabdoid meningiomas (Kaplan-Meier analysis, 26 mo vs 116 mo, P < .001; hazard ratio 12.89). A subset of patients with BAP1-deficient rhabdoid meningiomas harbored germline BAP1 mutations, indicating that rhabdoid meningiomas can be a harbinger of the BAP1 cancer predisposition syndrome. Conclusion: We define a subset of aggressive rhabdoid meningiomas that can be recognized using routine laboratory tests. We implicate ubiquitin deregulation in the pathogenesis of these high-grade malignancies. In addition, we show that familial and sporadic BAP1-mutated rhabdoid meningiomas are clinically aggressive, requiring intensive clinical management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/now235

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 43

  1. Louis DN Ohgaki H Wiestler OD WHO Classification of Tumours of the Central Nervous System . Revised 4th ed. Lyon, France: International Agency for Research on Cancer; 2016:232–257.
  2. 10.18632/oncotarget.2517 · DOI
  3. 10.1038/ng.2526 · DOI · Paper page
  4. 10.1126/science.1233009 · DOI · Paper page
  5. 10.1007/s00401-013-1093-x · DOI · Paper page
  6. 10.1038/ng.2552 · DOI · Paper page
  7. 10.1093/neuonc/nov316 · DOI · Paper page
  8. 10.1016/0092-8674(93)90406-G · DOI · Paper page
  9. 10.1002/path.4427 · doi:10.1002/path.4427
  10. 10.1097/00000478-199802000-00012 · doi:10.1097/00000478-199802000-00012
  11. 10.1097/00000478-199812000-00005 · doi:10.1097/00000478-199812000-00005
  12. Vaubel, 2016, Meningiomas with rhabdoid features lacking other histologic features of malignancy: a study of 44 cases and review of the literature, J Neuropathol Exp Neurol, 75, 44, 10.1093/jnen/nlv006 · DOI
  13. 10.1093/neuonc/nov247 · DOI
  14. 10.1016/j.cancergen.2015.03.005 · DOI
  15. 10.1038/ng.806 · DOI · Paper page
  16. 10.1101/gr.107524.110 · DOI · Paper page
  17. 10.1038/nbt.2514 · DOI · Paper page
  18. 10.1016/j.ajhg.2009.11.004 · DOI · Paper page
  19. 10.1038/nbt.2203 · DOI · Paper page
  20. 10.1038/nature09744 · DOI · Paper page
  21. 10.1093/bioinformatics/btr446 · DOI · Paper page
  22. 10.1093/bioinformatics/bts271 · DOI · Paper page
  23. 10.1158/2159-8290.CD-15-0369 · DOI · Paper page
  24. 10.1371/journal.pone.0038881 · DOI
  25. 10.1038/nrc3459 · DOI · Paper page
  26. 10.1038/nm.3739 · DOI · Paper page
  27. 10.1038/ncomms10086 · DOI · Paper page
  28. 10.1136/jmedgenet-2011-100156 · DOI · Paper page
  29. de la Fouchardiere, 2015, Primary leptomeningeal melanoma is part of the BAP1-related cancer syndrome, Acta Neuropathol, 129, 921, 10.1007/s00401-015-1423-2 · DOI
  30. 10.1016/j.ajhg.2013.04.012 · DOI · Paper page
  31. 10.1038/ng.912 · DOI · Paper page
  32. 10.1097/JTO.0000000000000471 · DOI · Paper page
  33. 10.1038/ng.3520 · DOI · Paper page
  34. van de Nes, 2016, Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma, Am J Surg Pathol, 40, 796, 10.1097/PAS.0000000000000645 · DOI
  35. 10.1111/bpa.12174 · DOI
  36. Sahm F Schrimpf D Olar A . TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst. 2016;108(5):. · DOI · Paper page
  37. 10.1111/bpa.12110 · DOI · Paper page
  38. Perry, 2002, A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas, Brain Pathol, 12, 183, 10.1111/j.1750-3639.2002.tb00433.x · doi:10.1111/j.1750-3639.2002.tb00433.x
  39. 10.1016/S0002-9440(10)61737-3 · DOI · Paper page
  40. 10.1093/neuonc/nov177 · DOI
  41. 10.1093/neuonc/not325 · doi:10.1093/neuonc/not325
  42. 10.1038/ng.2323 · DOI · Paper page
  43. 10.1038/nm.3947 · DOI · Paper page

Cited by

See all 184

Metadata

Authors
Shankar, G. M., Abedalthagafi, M., Vaubel, R. A., Merrill, P. H., Nayyar, N., Gill, C. M., Brewster, R., Bi, W. L., Agarwalla, P. K., Thorner, A. R., Reardon, D. A., Al-Mefty, O., Wen, P. Y., Alexander, B. M., van Hummelen, P., Batchelor, T. T., Ligon, K. L., Ligon, A. H., Meyerson, M., Dunn, I. F., Beroukhim, R., Louis, D. N., Perry, A., Carter, S. L., Giannini, C., Curry, W. T., Cahill, D. P., Barker, F. G., Brastianos, P. K., & Santagata, S.
Venue
Neuro-Oncology
Published
2016-11-10
Volume
19
Issue
4
Pages
now235
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W2554212574
Cited by
184
References
1
FWCI
10.63
Type
journal article
Language
en
Open access
bronze
Funders
  • King Abdulaziz City for Science and Technology (110968)
  • Susan G. Komen for the Cure
  • Conquer Cancer Foundation
  • American Brain Tumor Association

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. https://app.cochat.ai/papers/10.1093/neuonc/now235
The paper
Shankar, G. M., Abedalthagafi, M., Vaubel, R. A., Merrill, P. H., Nayyar, N., Gill, C. M., Brewster, R., Bi, W. L., Agarwalla, P. K., Thorner, A. R., Reardon, D. A., Al-Mefty, O., Wen, P. Y., Alexander, B. M., van Hummelen, P., Batchelor, T. T., Ligon, K. L., Ligon, A. H., Meyerson, M., . . . Santagata, S. (2016). Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/now235

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.